Jane Huang, incoming Prelude Therapeutics president and CMO
BeiGene hematology CMO Jane Huang makes a quick jump to a struggling biotech now juggling pipeline projects
Just days after we learned that BeiGene CMO of hematology Jane Huang was planning her exit, we now know what she’s doing next. Prelude Therapeutics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
